4130-5326 Screening compound: 7-[2-(4-benzylpiperazin-1-yl)-2-oxoethyl]-1,3-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione

4130-5326 Screening compound: 7-[2-(4-benzylpiperazin-1-yl)-2-oxoethyl]-1,3-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione
4130-5326 Screening compound: 7-[2-(4-benzylpiperazin-1-yl)-2-oxoethyl]-1,3-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione alternative view

Chemical Structure Depiction of ChemDiv screening compound 4130-5326
7-[2-(4-benzylpiperazin-1-yl)-2-oxoethyl]-1,3-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

4130-5326

Molecular Formula

C20H24N6O3 (C20 H24 N6 O3)

Compound Name

7-[2-(4-benzylpiperazin-1-yl)-2-oxoethyl]-1,3-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione

IUPAC name

7-[2-(4-benzylpiperazin-1-yl)-2-oxoethyl]-13-dimethyl-2367-tetrahydro-1H-purine-26-dione

SMILES

CN(c1c(C(N2C)=O)n(CC(N3CCN(Cc4ccccc4)CC3)=O)cn1)C2=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

396.45

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

0.260

Distribution Coefficient, logD

0.245

Water Solubility, LogSw

-1.35

Polar Surface Area

62.893

Acid Dissociation Constant (pKa)

17.97

Base Dissociation Constant (pKb)

5.96

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.00

4130-5326 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Ion Channels Focused Library (26372 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Nervous system
  • Cardiovascular
Targets:
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with 4130-5326 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 4130-5326?
Check Price and Availability of 4130-5326, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 4130-5326 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 4130-5326
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 4130-5326
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 4130-5326 available by request